Functional Parsing of Driver Mutations in the Colorectal Cancer Genome Reveals Numerous Suppressors of Anchorage-Independent Growth

被引:22
作者
Eskiocak, Ugur [1 ]
Kim, Sang Bum [1 ]
Ly, Peter [1 ]
Roig, Andres I. [1 ,2 ]
Biglione, Sebastian [1 ]
Komurov, Kakajan [3 ]
Cornelius, Crystal [1 ]
Wright, Woodring E. [1 ]
White, Michael A. [1 ]
Shay, Jerry W. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
关键词
TUMOR SUPPRESSORS; GENETIC SCREEN; HUMAN BREAST; CELLS; RAS; P53;
D O I
10.1158/0008-5472.CAN-11-0794
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Landmark cancer genome resequencing efforts are leading to the identification of mutated genes in many types of cancer. The extreme diversity of mutations being detected presents significant challenges to subdivide causal from coincidental mutations to elucidate how disrupted regulatory networks drive cancer processes. Given that a common early perturbation in solid tumor initiation is bypass of matrix-dependent proliferation restraints, we sought to functionally interrogate colorectal cancer candidate genes ( CAN-genes) to identify driver tumor suppressors. We have employed an isogenic human colonic epithelial cell ( HCEC) model to identify suppressors of anchorage-independent growth by conducting a soft agar-based short hairpin RNA (shRNA) screen within the cohort of CAN-genes. Remarkably, depletion of 65 of the 151 CAN-genes tested collaborated with ectopic expression of K-RAS(V12) and/or TP53 knockdown to promote anchorage-independent proliferation of HCECs. In contrast, only 5 of 362 random shRNAs (1.4%) enhanced soft agar growth. We have identified additional members of an extensive gene network specifying matrix-dependent proliferation, by constructing an interaction map of these confirmed progression suppressors with approximately 700 mutated genes that were excluded from CAN-genes, and experimentally verifying soft agar growth enhancement in response to depletion of a subset of these genes. Collectively, this study revealed a profound diversity of nodes within a fundamental tumor suppressor network that are susceptible to perturbation leading to enhanced cell-autonomous anchorage-independent proliferative fitness. Tumor suppressor network fragility as a paradigm within this and other regulatory systems perturbed in cancer could, in large part, account for the heterogeneity of somatic mutations detected in tumors. Cancer Res; 71( 13); 4359-65. (C) 2011 AACR.
引用
收藏
页码:4359 / 4365
页数:7
相关论文
共 20 条
  • [1] The functional contrariety of JNK
    Bode, Ann M.
    Dong, Zigang
    [J]. MOLECULAR CARCINOGENESIS, 2007, 46 (08) : 591 - 598
  • [2] Functional Identification of Tumor-Suppressor Genes through an In Vivo RNA Interference Screen in a Mouse Lymphoma Model
    Bric, Anka
    Miething, Cornelius
    Bialucha, Carl Uli
    Scuoppo, Claudio
    Zender, Lars
    Krasnitz, Alexander
    Xuan, Zhenyu
    Zuber, Johannes
    Wigler, Michael
    Hicks, James
    McCombie, Richard W.
    Hemann, Michael T.
    Hannon, Gregory J.
    Powers, Scott
    Lowe, Scott W.
    [J]. CANCER CELL, 2009, 16 (04) : 324 - 335
  • [3] Cancer-Specific High-Throughput Annotation of Somatic Mutations: Computational Prediction of Driver Missense Mutations
    Carter, Hannah
    Chen, Sining
    Isik, Leyla
    Tyekucheva, Svitlana
    Velculescu, Victor E.
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Karchin, Rachel
    [J]. CANCER RESEARCH, 2009, 69 (16) : 6660 - 6667
  • [4] Anoikis: A necessary death program for anchorage-dependent cells
    Chiarugi, Paola
    Giannoni, Elisa
    [J]. BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) : 1352 - 1364
  • [5] CDDO-Me Protects against Space Radiation-Induced Transformation of Human Colon Epithelial Cells
    Eskiocak, Ugur
    Kim, Sang Bum
    Roig, Andres I.
    Kitten, Erin
    Batten, Kimberly
    Cornelius, Crystal
    Zou, Ying S.
    Wright, Woodring E.
    Shay, Jerry W.
    [J]. RADIATION RESEARCH, 2010, 174 (01) : 27 - 36
  • [6] Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells
    Hiatt, KK
    Ingram, DA
    Zhang, YY
    Bollag, G
    Clapp, DW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) : 7240 - 7245
  • [7] A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity
    Kolfschoten, IGM
    van Leeuwen, B
    Berns, K
    Mullenders, J
    Beijersbergen, RL
    Bernards, R
    Voorhoeve, PM
    Agami, R
    [J]. CELL, 2005, 121 (06) : 849 - 858
  • [8] The CANCER GENOME challenge
    Ledford, Heidi
    [J]. NATURE, 2010, 464 (7291) : 972 - 974
  • [9] An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
    Min, Junxia
    Zaslavsky, Alexander
    Fedele, Giuseppe
    McLaughlin, Sara K.
    Reczek, Elizabeth E.
    De Raedt, Thomas
    Guney, Isil
    Strochlic, David E.
    MacConaill, Laura E.
    Beroukhim, Rameen
    Bronson, Roderick T.
    Ryeom, Sandra
    Hahn, William C.
    Loda, Massimo
    Cichowski, Karen
    [J]. NATURE MEDICINE, 2010, 16 (03) : 286 - U82
  • [10] Opposing effects of Ras on p53:: Transcriptional activation of mdm2 and induction of p19ARF
    Ries, S
    Biederer, C
    Woods, D
    Shifman, O
    Shirasawa, S
    Sasazuki, T
    McMahon, M
    Oren, M
    McCormick, F
    [J]. CELL, 2000, 103 (02) : 321 - 330